Trials / Completed
CompletedNCT02521857
A Water Consumption Study of ALKS 5461 in Healthy Volunteers
A Phase 1 Study to Evaluate the Impact of Water Consumption on the Pharmacokinetics of Sublingually Administered ALKS 5461
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Alkermes, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate the impact of water consumption on the pharmacokinetics of ALKS 5461.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ALKS 5461 | Sublingual tablet administered followed by consumption of 240 mL (8 ounces) of water at different timepoints |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2015-08-13
- Last updated
- 2015-11-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02521857. Inclusion in this directory is not an endorsement.